We observed that the numbers of Tbet+ICOS+ Th1-like CD4+ T cells in tumors correlated to reduced frequencies of CD45−CD31high tumor endothelial cells and increased frequencies of MECA-79+ TA-HECs after anti-CTLA-4 treatment (Figures 2K and 2L). This evidence concerns the gene CTLA4 and neoplasm.